Translational Findings Support Regimen Selection for First-in-human Study of Ubamatamab (MUC16 X CD3 Bispecific Antibody) in Patients with Recurrent Ovarian Cancer
CTS-CLINICAL AND TRANSLATIONAL SCIENCE(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要